Applied BioCode (Taiwan) Insiders
| 6598 Stock | TWD 24.05 0.60 2.56% |
Applied BioCode employs about 11 people. The company is managed by 11 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Applied BioCode's management performance can provide insight into the venture performance.
| Jaca Huang Insider Chief Officer |
| YuTsung Chou Insider Chief Officer |
Applied |
Applied BioCode Management Team Effectiveness
The company has return on total asset (ROA) of (0.0936) % which means that it has lost $0.0936 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1937) %, meaning that it generated substantial loss on money invested by shareholders. Applied BioCode's management efficiency ratios could be used to measure how well Applied BioCode manages its routine affairs as well as how well it operates its assets and liabilities.Applied BioCode holds a total of 81.76 Million outstanding shares. Applied BioCode retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Applied BioCode in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Applied BioCode, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Applied BioCode Workforce Comparison
Applied BioCode is rated second in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 218. Applied BioCode holds roughly 11.0 in number of employees claiming about 5% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of (0.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.47. Applied BioCode Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Applied BioCode Price Series Summation is a cross summation of Applied BioCode price series and its benchmark/peer.
Applied BioCode Notable Stakeholders
An Applied BioCode stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Applied BioCode often face trade-offs trying to please all of them. Applied BioCode's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Applied BioCode's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jaca Huang | Chief Officer | Profile | |
| YuTsung Chou | Chief Officer | Profile | |
| Michael Aye | Chief Officer | Profile | |
| Christopher Bernard | Chief Officer | Profile | |
| JauTung Pan | Accounting Supervisor | Profile | |
| Frank Mitchell | HR Director | Profile | |
| Julian Sanchez | Director HR | Profile | |
| Craig Adams | Sales Director | Profile | |
| Gerald Kowalski | VP Operations | Profile | |
| Winston Ho | President, Founder | Profile | |
| Parisa Hanachi | Marketing Director | Profile |
About Applied BioCode Management Performance
The success or failure of an entity such as Applied BioCode often depends on how effective the management is. Applied BioCode management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex testing products for the In-Vitro diagnostics market. The company was founded in 2016 and is based in Santa Fe Springs, California. APPLIED BIOCODE operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.
Please note, the imprecision that can be found in Applied BioCode's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied BioCode. Check Applied BioCode's Beneish M Score to see the likelihood of Applied BioCode's management manipulating its earnings.
Applied BioCode Workforce Analysis
Traditionally, organizations such as Applied BioCode use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Applied BioCode within its industry.Applied BioCode Manpower Efficiency
Return on Applied BioCode Manpower
| Revenue Per Employee | 29.1M | |
| Revenue Per Executive | 29.1M | |
| Net Loss Per Employee | 15M | |
| Net Loss Per Executive | 15M |
Additional Tools for Applied Stock Analysis
When running Applied BioCode's price analysis, check to measure Applied BioCode's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied BioCode is operating at the current time. Most of Applied BioCode's value examination focuses on studying past and present price action to predict the probability of Applied BioCode's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied BioCode's price. Additionally, you may evaluate how the addition of Applied BioCode to your portfolios can decrease your overall portfolio volatility.